The MIT-IBM Watson AI Research Member Program joins industry leading companies with research scientists from MIT and IBM in pursuit of leading-edge AI advances that hold the potential to transform how business is done.
The greatest advances in AI will come from the collective ideas and energy of researchers and stakeholders from across academia and industry.
The MIT-IBM Watson AI Lab welcomed Boston Scientific, Nexplore, Refinitiv and Samsung as inaugural members to the Membership Program. The Membership Program is tailored to each company’s goals as we collaborate to develop and apply AI advances to transform their business.
The Marlborough, Mass.-based medical solutions provider will interact with MIT and IBM researchers to help Boston Scientific as they address unmet patient needs with analytics and AI-related capabilities that can be applied across its businesses, including neuromodulation, interventional cardiology, heart rhythm management, peripheral interventions, endoscopy and urology.
Nexplore leads digital transformation efforts for many of the largest construction and mining companies in North America, Asia-Pacific and Europe. The team will interact with the Lab to apply AI algorithms that can help improve construction processes, such as monitoring concrete quality.
The global provider of financial markets data and infrastructure will focus on the Lab’s projects that could deliver more value to Refinitiv’s customers, such as uncovering financial forecasting surprises with knowledge graphs, and accelerating time to market to market for machine learning by transforming how models are trained.
Members have the ability to select projects from the MIT-IBM Watson AI Lab's broad portfolio.
Members can designate a ‘scholar in residence’ to work alongside IBM and participate with MIT and IBM researchers at events and technical summits.